In Brief This Week: PerkinElmer; DaVita, Roche; Unilabs, BGI; Intrexon; Agilent; Danaher; Sigma-Aldrich; GE Healthcare | GenomeWeb

NEW YORK (GenomeWeb News) – PerkinElmer reduced its headcount by 17 in the first quarter as part of a restructuring plan, it said in its Form 10-Q this week. The company recognized pre-tax restructuring charges of $400,000 and $200,000 in its Human Health segment and Environmental Health segment, respectively, as a result. PerkinElmer also shut down its Signature Genomics business subsequent to the end of the first quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genomic analysis of 200 bird species, and more.

The Australian High Court rules that isolated genetic material cannot be patented.

The startup incubator Y Combinator is launching a nonprofit research lab.

Tomas Lindahl, Paul Modrich, and Aziz Sancar share this year's Nobel Prize in Chemistry for their studies of DNA repair mechanisms.